PACS logo

PACS Group, Inc. (PACS) EBITDA

Annual EBITDA:

$166.39M-$106.12M(-38.94%)
December 31, 2024

Summary

  • As of today, PACS annual EBITDA is $166.39 million, with the most recent change of -$106.12 million (-38.94%) on December 31, 2024.
  • During the last 3 years, PACS annual EBITDA has risen by +$75.88 million (+83.83%).
  • PACS annual EBITDA is now -38.94% below its all-time high of $272.50 million, reached on December 31, 2023.

Performance

1-Year Change

-38.94%

3-Year Change

+83.83%

5-Year Change

+83.83%

15-Year Change

+83.83%

PACS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

87.97%
PACS annual EBITDA is higher than 87.97% of companies in Healthcare sector

Range

All-Time High

$272.50M
PACS annual EBITDA is currently -38.94% below its historical high of $272.50 million

3-Year Low

$90.51M
PACS annual EBITDA is currently +83.83% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
PACS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 30, 2026
PACS next annual earnings announcement is scheduled for Mar 30, 2026

OtherPACSincome statement metrics

Annual Revenue

$4.09B
PACS annual revenue is $4.09 billion

Annual Net Income

$55.34M
PACS annual net profit is $55.34 million

Annual EBIT

$125.58M
PACS annual earnings before interest & taxes is $125.58 million

Annual EPS

$0.36
PACS annual earnings per share is $0.36

Quarterly EBITDA:

$100.77M+$7.02M(+7.49%)
September 30, 2025

Summary

  • As of today, PACS quarterly EBITDA is $100.77 million, with the most recent change of +$7.02 million (+7.49%) on September 30, 2025.
  • Over the past year, PACS quarterly EBITDA has increased by +$66.44 million (+193.52%).
  • PACS quarterly EBITDA is now at all-time high.

Performance

3-Month Change

+7.49%

1-Year Change

+193.52%

3-Year Change

+53.55%

5-Year Change

+53.55%

PACS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

89.16%
PACS quarterly EBITDA is higher than 89.16% of companies in Healthcare sector

Range

All-Time High

$100.77M
PACS quarterly EBITDA is currently at an all-time high

3-Year Low

-$27.44M
PACS quarterly EBITDA is currently +467.25% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
PACS previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 30, 2026
PACS next earnings announcement is scheduled for Mar 30, 2026

OtherPACSincome statement metrics

Quarterly Revenue

$1.34B
PACS quarterly revenue is $1.34 billion

Quarterly Net Income

$52.33M
PACS quarterly net profit is $52.33 million

Quarterly EBIT

$86.37M
PACS quarterly earnings before interest & taxes is $86.37 million

Quarterly EPS

$0.32
PACS quarterly earnings per share is $0.32

TTM EBITDA:

$341.37M+$66.44M(+24.17%)
September 30, 2025

Summary

  • As of today, PACS TTM EBITDA is $341.37 million, with the most recent change of +$66.44 million (+24.17%) on September 30, 2025.
  • Over the past year, PACS TTM EBITDA has increased by +$260.84 million (+323.93%).
  • PACS TTM EBITDA is now at all-time high.

Performance

3-Month Change

+24.17%

1-Year Change

+323.93%

3-Year Change

+420.16%

5-Year Change

+420.16%

PACS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

88.71%
PACS TTM EBITDA is higher than 88.71% of companies in Healthcare sector

Range

All-Time High

$341.37M
PACS TTM EBITDA is currently at an all-time high

3-Year Low

$65.63M
PACS TTM EBITDA is currently +420.16% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
PACS previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 30, 2026
PACS next earnings announcement is scheduled for Mar 30, 2026

OtherPACSincome statement metrics

TTM Revenue

$5.14B
PACS TTM revenue is $5.14 billion

TTM Net Income

$167.87M
PACS TTM net profit is $167.87 million

TTM EBIT

$288.17M
PACS TTM earnings before interest & taxes is $288.17 million

TTM EPS

$1.04
PACS TTM earnings per share is $1.04

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$166.39M
PACS annual EBITDA is $166.39 million

Annual Net Income

$55.34M
PACS annual net profit is $55.34 million

Annual Interest Expense

$0.00
PACS annual interest expense is $0.00

Annual Income Tax

$46.21M
PACS annual income tax is $46.21 million

Annual D&A

$40.81M
PACS annual D&A is $40.81 million

PACS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-38.9%+193.5%+323.9%
3Y3 Years+83.8%+53.5%+420.2%
5Y5 Years+83.8%+53.5%+420.2%

PACS EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-38.9%+83.8%at high+467.3%at high+420.2%
5Y5-Year-38.9%+83.8%at high+467.3%at high+420.2%
All-TimeAll-Time-38.9%+83.8%at high+467.3%at high+420.2%

PACS EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$100.77M(+7.5%)
$341.37M(+24.2%)
Jun 2025
-
$93.75M(+53.7%)
$274.93M(+78.8%)
Mar 2025
-
$60.98M(-29.0%)
$153.74M(-7.6%)
Dec 2024
$166.39M
-
-
Dec 2024
-
$85.86M(+150.1%)
$166.39M(+106.6%)
Sep 2024
-
$34.33M(+225.1%)
$80.53M(-9.7%)
Jun 2024
-
-$27.44M(-137.3%)
$89.18M(-49.2%)
DateAnnualQuarterlyTTM
Mar 2024
-
$73.63M(+71.3%)
$175.63M(+4.8%)
Dec 2023
$272.50M(+8.3%)
-
-
Sep 2023
-
$42.99M(-27.1%)
$167.63M(+34.5%)
Jun 2023
-
$59.01M(-10.1%)
$124.64M(+89.9%)
Mar 2023
-
$65.63M
$65.63M
Dec 2022
$251.67M(+178.1%)
-
-
Dec 2021
$90.51M
-
-

FAQ

  • What is PACS Group, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for PACS Group, Inc.?
  • What is PACS Group, Inc. annual EBITDA year-on-year change?
  • What is PACS Group, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for PACS Group, Inc.?
  • What is PACS Group, Inc. quarterly EBITDA year-on-year change?
  • What is PACS Group, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for PACS Group, Inc.?
  • What is PACS Group, Inc. TTM EBITDA year-on-year change?

What is PACS Group, Inc. annual EBITDA?

The current annual EBITDA of PACS is $166.39M

What is the all-time high annual EBITDA for PACS Group, Inc.?

PACS Group, Inc. all-time high annual EBITDA is $272.50M

What is PACS Group, Inc. annual EBITDA year-on-year change?

Over the past year, PACS annual EBITDA has changed by -$106.12M (-38.94%)

What is PACS Group, Inc. quarterly EBITDA?

The current quarterly EBITDA of PACS is $100.77M

What is the all-time high quarterly EBITDA for PACS Group, Inc.?

PACS Group, Inc. all-time high quarterly EBITDA is $100.77M

What is PACS Group, Inc. quarterly EBITDA year-on-year change?

Over the past year, PACS quarterly EBITDA has changed by +$66.44M (+193.52%)

What is PACS Group, Inc. TTM EBITDA?

The current TTM EBITDA of PACS is $341.37M

What is the all-time high TTM EBITDA for PACS Group, Inc.?

PACS Group, Inc. all-time high TTM EBITDA is $341.37M

What is PACS Group, Inc. TTM EBITDA year-on-year change?

Over the past year, PACS TTM EBITDA has changed by +$260.84M (+323.93%)
On this page